Breadcrumb

2022 SCEP Keynote Speaker

Keynote Speaker

Jude Uzonna

Jude Uzonna, Ph.D., D.V.M.

Associate Dean (Research) and Professor of Immunology & Medical Microbiology 
Max Rady College of Medicine
University of Manitoba
 
 
Biography

Dr. Jude Uzonna is a professor in the departments of immunology and medical microbiology at the University of Manitoba. He was the Research Manitoba Chair Professor from 2010 to 2016, and is currently the associate dean (research) at the Max Rady College of Medicine.

Dr. Uzonna’s research focuses on understanding cellular and molecular mechanisms that regulate induction, maintenance and loss of protective immunity against parasitic infections with a goal to develop effective vaccines and/or vaccination strategies against these infections. He has mentored many trainees who are currently working in various fields including research, academia, and biotechnology.

He has been very successful in attracting millions of dollars in research funding from several organizations including the Canadian Institutes of Health Research, National Science and Engineering Research Council, Research Manitoba, etc. His research is currently funded by CIHR and NSERC.

 

Research Summary

Dr. Uzonna’s primary research program focuses on understanding cellular and molecular mechanisms that regulate the induction, maintenance and loss of protective immunity against parasitic infections, particularly those caused by protozoa, with a view to exploiting the information gained from these studies for the development of effective vaccines and vaccination strategies against these infections.

In addition, he is also interested in understanding the immunomodulatory mechanisms that regulate the pathophysiology of systemic inflammatory response syndromes, particularly those associated with sepsis and septic shock.


Selected Publications

Uzonna Publications

1. Regulation of Immunity in Breast Cancer. Edechi CA, Ikeogu N, Uzonna JE, Myal Y.
Cancers (Basel). 2019 Jul 30;11(8):1080. doi: 10.3390/cancers11081080.
PMID: 31366131

 

Front Immunol. 2020 Jun 12;11:1159. doi: 10.3389/fimmu.2020.01159. eCollection 2020.
PMID: 32595637
 
Immunol Res. 2013 May;56(1):163-71. doi: 10.1007/s12026-013-8389-8.
PMID: 23504228 
 
4. Leishmania Immunity: Advancing Immunotherapy and Vaccine Development. Ikeogu NM, Akaluka GN, Edechi CA, Salako ES, Onyilagha C, Barazandeh AF, Uzonna JE. 
Microorganisms. 2020 Aug 7;8(8):1201. doi: 10.3390/microorganisms8081201.
PMID: 32784615 

 

Front Immunol. 2021 May 19;12:671582. doi: 10.3389/fimmu.2021.671582. eCollection 2021.
PMID: 34093571